Key Takeaways
CCSD code 0019G is the UK private healthcare billing code for the EGFR vIII mutation test, a diagnostic pathology analysis that detects the EGFR variant III mutation in a tumor tissue sample.
0019G is a diagnostic service-charge code, not a procedural code: it is billed alongside the relevant consultation or procedure code rather than submitted as a standalone claim.
The test is used mainly in the diagnostic workup of glioblastoma and other high-grade gliomas, where EGFRvIII status can inform prognosis and eligibility for mutation-targeted treatment.
Major UK insurers including Bupa, AXA Health, Aviva, Vitality Health, and Allianz Care base their fee schedules on CCSD codes, but acceptance rules, pre-authorization requirements, and fees vary by insurer and contract.
Pabau’s claims management software supports electronic submission of CCSD-coded invoices via Healthcode, reducing manual errors and speeding up reimbursement for UK private practices.
CCSD code 0019G is the UK private healthcare billing code for the EGFR vIII mutation test, a molecular pathology analysis that looks for the epidermal growth factor receptor variant III (EGFRvIII) mutation in a submitted tumor tissue sample.
Clinicians order it mainly during the diagnostic workup of glioblastoma and other high-grade gliomas, where EGFRvIII status can affect prognosis and treatment planning. This guide covers what the test detects, how the code fits into insurer billing, and the documentation each claim needs.
CCSD code 0019G: Definition and clinical narrative
CCSD code 0019G is a diagnostic pathology code within the Clinical Coding and Schedule Development (CCSD) Group’s Schedule, the coding system used across UK private healthcare billing. It identifies the EGFR vIII mutation test, a molecular pathology analysis that detects the epidermal growth factor receptor variant III mutation in a submitted tumor tissue sample.
Private practices, consultants, and independent laboratories use CCSD codes on invoices submitted to private medical insurers (PMI) and self-pay patients. Getting the code right matters: billing 0019G for a test that was not the specific analysis performed is one of the most common triggers for claim rejection and audit in UK private practice.
For a broader overview of how these codes function across the system, see our complete Bupa CCSD code guide.
EGFRvIII results from a small deletion in the EGFR gene that locks the receptor’s growth signal in an active position, driving tumor cell proliferation. It is one of the most common genetic alterations detected in glioblastoma, and its presence can influence both prognosis and eligibility for EGFRvIII-targeted treatment or clinical trials.
Laboratories typically confirm it through immunohistochemistry or next-generation sequencing performed on resected or biopsied tumor tissue.
Because narratives and classification details are subject to revision through CCSD’s annual and interim bulletin process, practitioners should always verify the current narrative for 0019G directly in their CCSD schedule access before submitting a claim. The schedule is login-gated at ccsd.org.uk, and specific code narratives are available only to registered members and recognized providers.
The CCSD Technical Guide (updated October 2025) sets out the coding conventions that govern how all codes in the Schedule, including 0019G, are interpreted and applied. Practitioners working in UK private practice should treat the Technical Guide as essential reading alongside the Schedule itself.
CCSD code 0019G as a diagnostic code: Key distinctions
The CCSD schedule operates two separate frameworks: the Procedural Schedule for clinical interventions and the Diagnostic Schedule for diagnostic services such as pathology and molecular testing. CCSD code 0019G sits in the Diagnostic Schedule, alongside other pathology and molecular biomarker service-charge codes. It is not a surgical or consultant-procedure code, and it should not be billed as one.
- 0019G cannot stand alone. It must be submitted with a corresponding consultation or procedure code that reflects the clinical encounter, such as the biopsy or resection that produced the sample, or the appointment where results were reviewed.
- 0019G is not a procedure. Do not apply theater, anesthetist, or surgical assistant modifiers to this code.
- 0019G fees are insurer-set. CCSD assigns the code and descriptor; each private medical insurer (PMI) sets its own reimbursement value, so verify the rate with the specific payer.
Understanding which schedule a code sits in avoids early billing mistakes: a diagnostic code billed like a procedure, or vice versa, is a frequent source of claim queries for practices new to CCSD billing.
Which insurers accept CCSD code 0019G?
All major UK private medical insurers (PMI) base their fee schedules on CCSD codes. Whether CCSD code 0019G is reimbursable under a specific policy depends on the insurer, the patient’s policy terms, and the clinical context of the claim.
Below is a summary of how the principal UK insurers handle CCSD-coded claims, with links to their current resources for verifying coverage of specific codes.
Fee amounts for 0019G are not fixed uniformly across all insurers. Each insurer negotiates its own fee schedule, and recognized providers may receive different rates depending on their individual recognition agreement. Never quote a patient a fixed reimbursement figure based on what one insurer pays. Always check your recognition agreement and the insurer’s current published schedule before billing.
Pre-authorization rules for CCSD code 0019G
Pre-authorization requirements for CCSD code 0019G vary by insurer and by individual patient policy. Some insurers require prior approval for all services above a certain cost threshold; others require it only for specified categories of treatment.
A claim submitted without required pre-authorization is almost certain to be declined, regardless of how correctly the code has been applied. Practitioners moving into private practice should establish a clear pre-authorization workflow as a standard step before treating any insured patient.
- Before booking: Confirm with the patient whether their policy requires pre-authorization for the planned procedure.
- Before billing: Obtain written pre-authorization from the insurer and record the authorization number in the patient file.
- On the invoice: Include the pre-authorization number on every claim submission where one was obtained.
- After treatment: If circumstances change mid-procedure and additional codes are needed, contact the insurer before submitting to agree on coverage for any additions.
Pre-authorization is not a guarantee of payment. Insurers retain the right to review claims after the fact and may decline payment if the documented procedure does not match the authorized treatment plan. Accurate, contemporaneous clinical notes are your best protection if a claim is subsequently queried.
Pro Tip
Contact the insurer’s provider line before the patient’s appointment for any procedure where coverage of CCSD code 0019G is unclear. Get the authorization number and the name of the agent who confirmed it. A five-minute call before treatment protects against a delayed or declined claim that can take weeks to resolve.
Documentation requirements for CCSD code 0019G
Robust clinical documentation is the evidentiary foundation of every claim in UK private healthcare. When an insurer queries or audits a CCSD code 0019G claim, the clinical record must demonstrate that the test described in the code’s narrative was performed, that it was clinically appropriate, and that all relevant patient consent and safety steps were completed.
Practices that are also subject to Care Quality Commission (CQC) inspection should note that documentation standards overlap significantly with CQC’s requirements for evidence of safe, person-centred care. A CQC inspection checklist can help align your documentation processes with both billing and regulatory expectations.
What to include in the clinical record
- Patient identification: Full name, date of birth, and insurance policy number.
- Referral details: Referring clinician name and GMC number where a consultant referral is required by the insurer’s policy terms.
- Clinical indication: Clear documentation of the presenting condition or symptom that made the procedure necessary.
- Procedure record: A contemporaneous note of what was performed, including technique, findings, and any complications or deviations from the planned approach.
- Outcome and follow-up: Post-procedure assessment and any follow-up plan documented at the time of treatment.
- Consent: Written informed consent signed before the procedure, confirming the patient understood the nature of the treatment and associated risks.
UK GDPR and the Data Protection Act 2018 govern how patient records are stored and accessed. Your practice’s data handling processes must be compliant with both the Information Commissioner’s Office (ICO) requirements and your insurer’s data-sharing obligations.
Using digital clinical forms that are encrypted, access-controlled, and automatically timestamped removes much of the manual compliance burden from clinical teams. Maintaining a clear UK GDPR compliance checklist alongside your billing workflow reduces risk across both fronts simultaneously.

How to submit a CCSD code 0019G claim
Electronic claim submission via Healthcode is the standard route for UK private healthcare billing. Healthcode is the recognized electronic billing network for UK PMI, and all major insurers accept Healthcode-transmitted invoices.
Paper submission is still technically possible with some insurers but is slower, more error-prone, and increasingly deprioritized by insurer processing teams. Practices leaving the NHS for private practice often underestimate how much the submission infrastructure differs from NHS systems.
Step-by-step submission process
- Verify the narrative: Confirm the current CCSD code 0019G narrative matches exactly what was performed. Do this before raising the invoice, not after.
- Confirm recognition status: Ensure your practice holds a valid recognition agreement with the patient’s insurer. Claims from non-recognized providers are automatically rejected by most PMI.
- Obtain pre-authorization: If the insurer or policy requires it, obtain and record the authorization number before submitting.
- Raise the invoice: Include the patient’s policy number, date of service, CCSD code 0019G with the full narrative, the fee charged, and the pre-authorization number where applicable.
- Submit via Healthcode: Transmit the invoice electronically through your Healthcode-connected billing system. Pabau’s claims management software integrates with Healthcode to support direct electronic submission.
- Track the claim: Monitor acknowledgement and payment status. Follow up within 30 days if no response has been received.
Practices managing multiple CCSD-coded invoices across several insurers benefit significantly from practice management software that provides a unified view of claim status, outstanding balances, and rejection reasons. Clinicians in multi-specialty or private GP settings with cross-referral workflows particularly benefit from centralized claim tracking.
Submit CCSD claims without the manual back-and-forth
Pabau connects your clinical records to electronic claim submission via Healthcode, so your team spends less time on paperwork and more time on patients.
Common claim errors for CCSD code 0019G
Most CCSD claim rejections in UK private practice are caused by a small number of recurring errors. Understanding them upfront reduces the administrative cost of resubmissions and protects cash flow. For practices focused on choosing the right billing software, eliminating avoidable rejections at submission is one of the highest-leverage changes a billing team can make.
Narrative mismatch
Billing CCSD code 0019G when the documented procedure aligns with a different code’s narrative is the most serious error. It can be read as upcoding or incorrect billing, which triggers formal audit processes with some insurers. Always cross-reference the code narrative against the clinical note before submitting.
Missing or incorrect pre-authorization number
Submitting a claim without the required authorization number, or with an incorrect or expired number, results in automatic rejection at most insurers. Build a checklist into the patient booking and invoicing workflow so no claim leaves without a verified authorization reference where the policy requires one.
Bundling and unbundling errors
The CCSD Technical Guide contains explicit rules on which codes can be billed together and which are considered included within another code’s scope. Billing 0019G alongside a code that subsumes it (or vice versa) constitutes unbundling, which insurers including Healix actively audit. Always check the CCSD Technical Guide’s bundling rules before combining codes on a single invoice.
Stale code narrative
CCSD publishes periodic bulletins that amend code narratives, add new codes, and retire obsolete ones. A code narrative that was accurate in a previous financial year may have been revised. Subscribe to CCSD bulletin updates and update your billing system’s procedure code table whenever a bulletin is released.
Non-recognized provider status
If the treating clinician is not individually recognized by the patient’s insurer, the claim will be rejected regardless of how accurately the code has been applied. Ensure all clinicians in your practice maintain up-to-date recognition agreements with the relevant PMI before treating insured patients.
Practices offering dermatology and aesthetic services should review their insurer recognition status regularly, as recognition can be insurer-specific by specialty.
Pro Tip
Run a monthly audit of your outstanding CCSD-coded claims. Flag any invoice older than 30 days with no payment or acknowledgement. Most UK insurers commit to processing clean claims within 14-21 working days. Persistent delays often signal a documentation issue or a policy coverage query that can be resolved faster with a direct call to the insurer’s provider relations team.
CCSD coding principles that apply to 0019G
The CCSD Group publishes coding principles that govern interpretation across the entire Schedule. These principles apply to all codes, including 0019G, and understanding them helps practitioners avoid technical billing errors that are not immediately obvious from the code narrative alone.
The CCSD Coding Principles Bulletin (most recently the January 2025 edition) consolidates updates to these rules. Practices using private practice management software should ensure their procedure code tables reflect the most current CCSD Schedule and bulletin amendments.
- Code to the highest specificity: Where a more specific code exists for the exact procedure performed, use it in preference to a general code. 0019G should only be used when its narrative is the closest match to the documented activity.
- One code per procedure episode: A procedure performed once during a single operative session should be billed once. Duplicate billing of the same code within the same session is a common audit trigger.
- Associated procedures: Some procedures that are integral to a primary procedure are not separately billable. The Technical Guide specifies which associated activities are included within a code’s scope.
- Single-specimen submission: 0019G is billed once per tumor sample submitted for EGFRvIII analysis. It is a lab test on a single specimen, not a bilateral anatomical procedure, so bilateral billing rules do not apply.
- Repeat testing: EGFRvIII testing may be repeated when a new tissue sample becomes available, such as at recurrence, but each submission must be supported by its own dated pathology report. Do not bill 0019G more than once against a single specimen.
Related CCSD and procedure codes
Not every code with a “G” suffix in the CCSD Schedule is diagnostic. CCSD code 0021G is a procedural code, which illustrates why the prefix and suffix pattern alone should never be used to guess whether a code sits in the Procedural or the Diagnostic Schedule; always confirm the schedule and narrative directly.
Practices billing across multiple coding systems for cancer care may also handle supportive-care drug codes, such as HCPCS code J1626 for granisetron hydrochloride, an antiemetic sometimes used alongside chemotherapy or radiotherapy in glioma patients, or remote monitoring codes like CPT code 98980 for practices that also submit US claims.
Conclusion
Billing CCSD code 0019G accurately in UK private practice depends on three things: knowing the current narrative, understanding insurer-specific acceptance and pre-authorization rules, and maintaining clinical documentation that withstands audit. The CCSD Schedule and Technical Guide are the definitive references, and both should be reviewed before submitting any claim under this code.
Pabau’s compliance management software supports UK private practices with Healthcode-connected electronic submission, structured invoice workflows, and claim tracking, so your team can focus on patient care rather than chasing rejections. To see how Pabau handles private practice billing end-to-end, book a demo.
Continue your research
Need a full reference for Bupa procedure codes? Bupa CCSD codes: complete guide for UK practices covers how to find the right code, avoid common denials, and streamline electronic submission.
Switching from NHS to private billing for the first time? Leaving the NHS for private practice explains the key operational and billing differences to plan for.
Want to understand how UK private practice billing software works? Best medical billing software in the UK (2026) outlines which platforms fit private practices handling CCSD billing.
Frequently Asked Questions
CCSD code 0019G is the UK private healthcare billing code for the EGFR vIII mutation test, a diagnostic pathology analysis that detects the EGFR variant III mutation in a tumor tissue sample, used mainly in the diagnostic workup of glioblastoma and other high-grade gliomas. It belongs to the CCSD Diagnostic Schedule, not the Procedural Schedule, and the exact narrative should be verified in the login-gated CCSD schedule at ccsd.org.uk before any claim is submitted.
Most major UK PMI, including Bupa, AXA Health, Aviva, Vitality Health, Allianz Care, Healix, WPA, and H3 Insurance, base their fee schedules on CCSD codes. Whether 0019G is reimbursable under a specific patient’s policy depends on that policy’s terms and the clinical indication. Always verify coverage with the insurer before treating an insured patient.
Fees for CCSD code 0019G are set individually by each insurer and vary by recognition agreement and contract level. Use Bupa’s code search portal, Vitality’s fee finder, Healix’s fee schedule, or your individual recognition agreement documents to look up the current fee. Never quote patients a fee based on what a different insurer pays.
You need contemporaneous clinical notes documenting the procedure performed, the clinical indication, the patient’s consent, referral details if required by the insurer, and the pre-authorization number where applicable. The documentation must demonstrate that the procedure matches the narrative of CCSD code 0019G, not an adjacent code with a similar description.
The most common rejection reasons are narrative mismatch between the billed code and the documented procedure, missing pre-authorization number, bundling errors where 0019G is billed alongside a code that subsumes it, an outdated code narrative following a CCSD bulletin update, and non-recognized provider status for the treating clinician.